Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kent E. Pryor

Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3k3a-Apc, a Recombinant Variant of Human Activated Protein C, in Combination With Tissue Plasminogen Activ

Annals of Neurology

Neurology

2019

English

Related publications

Efficacy and Safety of Elagolix in a Subgroup of Women With Uterine Fibroids and Adenomyosis: Results From a Phase 2 Trial

Fertility and Sterility

Gynecology

Reproductive Medicine

Obstetrics

2018

English

Miscellanea. A Stopping Rule for the Continual Reassessment Method

English

Final Safety Results of a Phase 1 Clinical Trial of Afatinib in Combination With Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

International Journal of Radiation Oncology Biology Physics

English

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

English

A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects

Journal of Nuclear Medicine

English

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2020

English

Multi-Centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults With Growth Hormone Deficiency

Journal of Endocrinological Investigation

English

Tailored Postoperative Treatment of Prostate Cancer: Final Results of a Phase I/Ii Trial

Prostate Cancer and Prostatic Diseases

English

A Method to Determine Stroke Trial Success Using Multidimensional Pooled Control Functions

Stroke

Cardiology

Neurology

Cardiovascular Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kent E. Pryor

Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3k3a-Apc, a Recombinant Variant of Human Activated Protein C, in Combination With Tissue Plasminogen Activ

Related publications

Efficacy and Safety of Elagolix in a Subgroup of Women With Uterine Fibroids and Adenomyosis: Results From a Phase 2 Trial

Miscellanea. A Stopping Rule for the Continual Reassessment Method

Final Safety Results of a Phase 1 Clinical Trial of Afatinib in Combination With Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Multi-Centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults With Growth Hormone Deficiency

Tailored Postoperative Treatment of Prostate Cancer: Final Results of a Phase I/Ii Trial

A Method to Determine Stroke Trial Success Using Multidimensional Pooled Control Functions